Randomised controlled trial of aripiprazole for treatment of auditory verbal hallucinations in borderline personality disorder

阿立哌唑治疗边缘性人格障碍幻听的随机对照试验

• 批准号: nhmrc : 1102595
• 负责人: A/Pr C. Barnaby Nelson
• 金额: $ 189.29万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2016
• 资助国家: 澳大利亚
• 起止时间: 2016-01-01 至 2020-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/randomised-controlled-trial-personality-disorder/662618
• 关键词: Randomised; controlled; trial; aripiprazole; treatment

People with borderline personality disorder (BPD) often report hearing voices. There is no consensus about how to treat these symptoms. Our study aims to address this clinical problem by conducting a 12 week trial of antipsychotic medication in patients who hear voices and have a diagnosis of BPD. The study will examine the effect of this medication on the nature of these voices, as well as other aspects of mental illness and brain functioning. The results will directly inform clinical practice.

边缘型人格障碍（BPD）患者经常报告听到声音。对于如何治疗这些症状没有共识。我们的研究旨在通过对听到声音并诊断为BPD的患者进行为期12周的抗精神病药物试验来解决这一临床问题。这项研究将检查这种药物对这些声音的性质以及精神疾病和大脑功能的其他方面的影响。结果将直接告知临床实践。